Company growth at NorthStar Medical Radioisotopes remains uninterrupted by COVID-19, according to CEO Steve Merrick.
Work continues at the headquarters on a new electron accelerator production building to expand capacity of the company’s non-uranium domestic supply of molybdenum-99 (Mo-99). “Construction has continued without interruption,” Merrick said.
The accelerator project coincides with the isotope processing facility that saw construction in 2019. The processing facility, built directly next to the in-progress accelerator building, will help the company avoid shipping delays between irradiation and processing of Mo-99. Equipment installation at the processing facility remains underway, Merrick added.
To read more please visit:
Source: Beloit Daily News